APW
LEGN icon

Aventura Private Wealth’s Legend Biotech LEGN Stock Holding History

Aventura Private Wealth’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51
Closed -$1.73K – 813
2025
Q1 		$1.73K Hold
51
– – ﹤0.01% 618
2024
Q4 		$1.66K Buy
+51
New +$2.11K ﹤0.01% 597

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Aventura Private Wealth's LEGN Position: Q2 2025 in Review

Aventura Private Wealth sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 51 shares — an estimated $1.73K sold.

Aventura Private Wealth first reported a position in LEGN in Q4 2024 and held it in 2 quarters. The position peaked at $1.73K in Q1 2025. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Aventura Private Wealth reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 51 Legend Biotech shares in Q2 2025, an estimated $1.73K.
  • Aventura Private Wealth first reported a position in Legend Biotech in Q4 2024 and held it in 2 quarters.
  • Aventura Private Wealth's Legend Biotech position peaked at $1.73K in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Aventura Private Wealth's 13F filing for Q2 2025, filed 7 Jan 2026.